Characterization of human interferon-gamma receptor purified from placenta. 1989

S Stefanos, and Y H Ahn, and S Pestka
University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Department of Molecular Genetics and Microbiology, Piscataway 08854-5635.

Membranes prepared from human placenta were used for characterization of the receptor for human interferon-gamma (HuIFN-gamma) after large-scale purification. HuIFN-gamma linked covalently to Affigel-10 was used for the purification of the receptor from octylglucoside-solubilized placental membranes. Radiolabeled IFN-gamma [32P]HuIFN-gamma, was used in binding and cross-linking studies to detect the receptor at different stages of the purification. From binding assays it was calculated that an average placenta contained 90-120 micrograms of receptor with a Kd value of 1.3 x 10(-9) M. Thus, human placenta is a rich and convenient source of receptor for IFN- gamma. When purified receptor was cross-linked to [32P]HuIFN-gamma, a variety of cross-linked bands were detected dependent on the preparation conditions. The use of protease inhibitors in the course of processing prevented degradation of the 90-kD intact receptor, showing that the lower-molecular-weight products detected in previous studies are degradation products of the receptor. Furthermore, a 20-kD fragment of the receptor was found to be active in binding HuIFN-gamma.

UI MeSH Term Description Entries
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D010920 Placenta A highly vascularized mammalian fetal-maternal organ and major site of transport of oxygen, nutrients, and fetal waste products. It includes a fetal portion (CHORIONIC VILLI) derived from TROPHOBLASTS and a maternal portion (DECIDUA) derived from the uterine ENDOMETRIUM. The placenta produces an array of steroid, protein and peptide hormones (PLACENTAL HORMONES). Placentoma, Normal,Placentome,Placentas,Placentomes
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011971 Receptors, Immunologic Cell surface molecules on cells of the immune system that specifically bind surface molecules or messenger molecules and trigger changes in the behavior of cells. Although these receptors were first identified in the immune system, many have important functions elsewhere. Immunologic Receptors,Immunologic Receptor,Immunological Receptors,Receptor, Immunologic,Receptors, Immunological
D003432 Cross-Linking Reagents Reagents with two reactive groups, usually at opposite ends of the molecule, that are capable of reacting with and thereby forming bridges between side chains of amino acids in proteins; the locations of naturally reactive areas within proteins can thereby be identified; may also be used for other macromolecules, like glycoproteins, nucleic acids, or other. Bifunctional Reagent,Bifunctional Reagents,Cross Linking Reagent,Crosslinking Reagent,Cross Linking Reagents,Crosslinking Reagents,Linking Reagent, Cross,Linking Reagents, Cross,Reagent, Bifunctional,Reagent, Cross Linking,Reagent, Crosslinking,Reagents, Bifunctional,Reagents, Cross Linking,Reagents, Cross-Linking,Reagents, Crosslinking
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D017471 Receptors, Interferon Specific molecular sites or structures on or in cells with which interferons react or to which they bind in order to modify the function of the cells. Interferons exert their pleiotropic effects through two different receptors. alpha- and beta-interferon crossreact with common receptors, while gamma-interferon initiates its biological effects through its own specific receptor system. Interferon Receptors,Interferon Receptor,Receptor, Interferon

Related Publications

S Stefanos, and Y H Ahn, and S Pestka
July 1988, Proceedings of the National Academy of Sciences of the United States of America,
S Stefanos, and Y H Ahn, and S Pestka
May 1988, Journal of immunology (Baltimore, Md. : 1950),
S Stefanos, and Y H Ahn, and S Pestka
January 1983, Placenta,
S Stefanos, and Y H Ahn, and S Pestka
July 1995, Biochemical and biophysical research communications,
S Stefanos, and Y H Ahn, and S Pestka
August 1986, Biochemical and biophysical research communications,
S Stefanos, and Y H Ahn, and S Pestka
January 1983, The International journal of biochemistry,
S Stefanos, and Y H Ahn, and S Pestka
January 1989, Life sciences,
S Stefanos, and Y H Ahn, and S Pestka
June 1981, Acta pathologica et microbiologica Scandinavica. Section C, Immunology,
S Stefanos, and Y H Ahn, and S Pestka
June 1987, The Journal of biological chemistry,
Copied contents to your clipboard!